Featured Research

from universities, journals, and other organizations

Novel Prostate Cancer Vaccine Study Under Way At Indiana University School Of Medicine

Date:
June 8, 2000
Source:
Indiana University
Summary:
Indiana University Cancer Center is investigating a new vaccine for treating prostate cancer that has spread beyond the prostate gland.

INDIANAPOLIS -- Indiana University Cancer Center is investigating a new vaccine for treating prostate cancer that has spread beyond the prostate gland.

Vaccination against disease is not a new concept, but in the arena of cancer therapies it is viewed as a possible way to kill malignant cells without damaging healthy cells. In this case, the therapy holds promise because it provides an avenue for treating the malignant cells before they become symptomatic.

Participants in the trial are men who have already undergone surgery or radiation therapy for prostate cancer. Subsequent blood tests for prostate specific antigen indicated their cancer has spread. PSA is produced by the prostate, but patients enrolling in this trial have had their prostates removed or treated with radiation so their PSA levels should be very low or undetectable. Participants in the trial must have no symptoms or findings of disease recurrence other than the elevated PSA.

"Because of the PSA blood test, recurrence of prostate cancer can be detected at an earlier stage than it could be previously," said Christopher Sweeney, M.D., an oncologist at the IU School of Medicine and one of the physicians treating trial participants. "It is hoped the vaccine will boost the patient's immune system and eliminate the cancer while it is still at a low level in the body."

Two vaccines are being tested to determine which treatment regimen is most effective. One uses the vaccinia virus, a relatively harmless virus used in smallpox vaccines, and the second uses the fowlpox vaccine. Both are genetically altered viruses that have been changed to express human PSA. The PSA-bearing virus is attacked by the human immune system and, ideally, the body simultaneously will attack the PSA tumor cells.

Patients are treated with four injections six weeks apart and then followed for at least six months to determine if the PSA tumor cells were eradicated. The IU Cancer Center is one of five sites nationwide enrolling patients for the Phase II trial. The trial is sponsored by the Eastern Cooperative Oncology Group, a national cancer clinical trial cooperative group funded by the National Cancer Institute.

###

People seeking additional information or who want to enroll in the trial may call Karen Fife at 317-274-2552.


Story Source:

The above story is based on materials provided by Indiana University. Note: Materials may be edited for content and length.


Cite This Page:

Indiana University. "Novel Prostate Cancer Vaccine Study Under Way At Indiana University School Of Medicine." ScienceDaily. ScienceDaily, 8 June 2000. <www.sciencedaily.com/releases/2000/06/000608072243.htm>.
Indiana University. (2000, June 8). Novel Prostate Cancer Vaccine Study Under Way At Indiana University School Of Medicine. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2000/06/000608072243.htm
Indiana University. "Novel Prostate Cancer Vaccine Study Under Way At Indiana University School Of Medicine." ScienceDaily. www.sciencedaily.com/releases/2000/06/000608072243.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins